Advanced Oncotherapy announced a partnership agreement with DiaMedCare AG. Under the terms of the agreement, Advanced Oncotherapy will be able to offer its customers easier access to the Company's LIGHT system through a flexible financing solution that reduces the need for large initial upfront payments from customers. The partnership agreement will cover projects in Europe and the United States, in line with the Company's aim to democratise proton beam therapy. This partnership is a key step forward in the Company's commercialisation strategy as it offers Advanced Oncotherapy's customers the opportunity to access LIGHT systems at a much more affordable price. DiaMedCare's leasing solutions work very well with Advanced Oncotherapy's business model, given LIGHT's modularity and easy installation. This partnership will allow for the democratisation of proton therapy by deploying LIGHT systems in smaller clinics and urban environments compared with other systems on the market that require large installation sites and significant shielding. Under the terms of the partnership agreement, DiaMedCare will acquire LIGHT systems and lease them back to the Company's customers that are commissioning the LIGHT system for oncology treatments. In addition, DiaMedCare will also be able to bridge manufacturing costs until delivery of the LIGHT system to customers. The terms of any financing solutions provided by DiaMedCare will be specific to each project and will be subject to definitive agreements being entered into between the Company, DiaMedCare and the customer.